Next 10 |
COPENHAGEN, Denmark, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”), today announced that that on December 16, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that Nasdaq beli...
COPENHAGEN, Denmark, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”), today announced that the Enlarged Board of Appeal (the “EBA”) of the European Patent Office (the “EPO”) has denied Forward...
Forward Pharma press release (NASDAQ:FWP): FY GAAP EPS of -$0.02. At December 31, 2021, the Group had cash and cash equivalents of $70.8M and working capital of $70.8M. "We believe we have sufficient liquidity to allow us to meet our planned operating activities in the normal course of busine...
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year end...
The Australian government has awarded Forward Pharma (FWP +4.2%) a key patent linked to multiple sclerosis (MS) therapy. According to the details published by IP Australia Thursday, the patent bearing the application number 2019268049 is titled “pharmaceutical composition con...
Gainers: ZIOPHARM Oncology (NASDAQ:ZIOP) +39%, RenovoRx (NASDAQ:RNXT) +17%, Sigilon Therapeutics (NASDAQ:SGTX) +17%, Acumen Pharmaceuticals (NASDAQ:ABOS) +15%, NeuroOne Medical Technologies (NASDAQ:NMTC) +7%. Losers: CorMedix (NASDAQ:CRMD) -25...
Jaguar Health (NASDAQ:JAGX) -21% slumps 10% on 1-for-3 reverse stock split announcement. Forward Pharma (NASDAQ:FWP) -17% after Technical Board of Appeal of the European Patent Office has dismissed Forward’s appeal of the previous decision of the EPO Opposition Division ...
COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”) of the European Patent Office (the “EPO...
Gainers: Intec Pharma (NASDAQ:NTEC) +61%. LendingClub Corporation (NYSE:LC) +55%. NanoVibronix (NASDAQ:NAOV) +36%. Golden Star Resources (NYSE:GSS) +28%. Dream Finders Homes (NASDAQ:DFH) +17%. E-Home Household Service Holdings (NASDAQ:EJH) +17%. Tempur Sealy International (NYSE:TPX) +16%. Hut...
Gainers: NanoVibronix (NASDAQ:NAOV) +49%, Intec Pharma (NASDAQ:NTEC) +31%, Cocrystal Pharma (NASDAQ:COCP) +17%, Burning Rock Biotech (NASDAQ:BNR) +11%, Genetron (NASDAQ:GTH) +8%. Losers: Annovis Bio (NYSE:ANVS) -48%, Atreca (NASDAQ:BCEL) -35%,...
News, Short Squeeze, Breakout and More Instantly...
COPENHAGEN, Denmark, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”), today announced that that on December 16, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that Nasdaq beli...
COPENHAGEN, Denmark, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”), today announced that the Enlarged Board of Appeal (the “EBA”) of the European Patent Office (the “EPO”) has denied Forward...
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year end...